Medical Foam Market

Medical Foam Market Size (2023-2028):

The Medical Foam Market size was estimated at USD 29.5 billion in 2022 and it is predicted to reach USD 39.5 billion in 2028, with an annual rate of 8.9% between 2022 and 2028.

Key factors for the expansion of this industry are the growing population aging, rising worldwide spending on healthcare, expansion of the implantable device industry, and the shift from traditional products to advanced wound care. The medical-grade foam contains specific antimicrobial substances to reduce the risk of spreading bacteria, germs, and diseases in hospitals or other medical areas due to its contaminant-resistance property. Medical foam products are highly critical to the medical industry due to increased infections, contamination, and disease. Medical grade foams are specially classified as biocompatible, non-toxic, low particle, and sterilized products that are formulated for various applications in the medical industry to face various challenges present in medical environments. These foams are mainly employed to clean rooms for antibacterial applications to reduce the risk of diseases, and germs, which are spread in hospitals due to the resistance of the foam to contaminants. These foams are gaining popularity in the medical industry due to various factors, such as technological advancements in the healthcare industry, which have led to the shift to foam-based wound care systems derived from the healthcare system. human. Traditional wounds and an escalating number of surgical procedures worldwide.

The worldwide emphasis on periodic cleaning and health and the call for high-quality health products that can meet the need for various medical applications are creating the call for medical foams. Medical foams have attained a high reputation in the healthcare industry in the last 20 years owing to their great uses. A recent development in manufacturing technology has resulted in the creation of medical foams that offer fungal resistance, stain resistance, low degassing, and excellent shock absorption. Medical foams are also employed for packaging specialized products and medical devices, as they provide security against adverse weather conditions and any type of external resistance. Therefore, they guarantee the safety of the product during transport and give manufacturers and consumers a feeling of confidence in the quality of the packaged product. Medical foams have made a significant contribution to the medical industry. Overall, the worldwide medical foam industry is predicted to experience positive expansion during the foreseen period.

Medical Foam Market Drivers:

The growing worldwide population and growing consumer concerns for health and cleanliness are escalating the call for high-quality medical foam suitable for various applications. This factor is also predicted to continue to drive the worldwide industry for medical foams during the foreseen period. The rapid expansion of the healthcare industry worldwide is also driving call for medical foams, which is likely to drive expansion in the global medical foams market in the future. Furthermore, the use of medical foams for packaging various medical devices and pharmaceuticals appears to be a key factor in the expansion of the medical foam industry.

Restraints in the Medical Foam Market:

Some of the factors that inhibit the expansion of the worldwide industry for medical foams include strict rules and regulations imposed on the use of medical-grade products, which require high research and development costs, and greater investments in the health industry.

Opportunities in the Medical Foam Market:

The increasing consumer knowledge related to the benefits of medical polymeric foam is supposed to create immense possibilities in the industry in futre. The growing population is driving the call for high-quality medical products that help expand the worldwide industry for medical foams. Escalating industrialization is leading to an increase in the configuration of the medical foam industries, which in turn is driving the worldwide industry. The high production call for sterile medical equipment and the aging population are accelerating the expansion of the worldwide industry. Fundraisings and government grants are also predicted to drive expansion in the worldwide industry. The low cost of these medical foam products helps to increase sales in various regions and accelerate the expansion of the worldwide industry. Low-cost labor coupled with low cost of ownership attributed to the expansion of the worldwide industry for medical foams.

Challenges in the Medical Foam Market:

While the future of the industry looks bright, several factors act as black spots in the landscape. The strict regulatory framework makes it difficult to obtain certification for new products, which in turn hinders the expansion of the global industry for medical foams. Moreover, the high prices of technologically developed goods hamper the widespread adoption of medical foams, mainly in growing and less advanced nations.

MEDICAL FOAM MARKET REPORT COVERAGE:

Medical Foam Market Segmentation as per the research report until 2028.

Medical Foam Market - By Form:

• Flexible

• Rigid

• Spray

The flexible segment accounted for the largest share of the global medical foam industry in 2019 and is predicted to post a significant expansion rate during the foreseen period.

Medical Foam Market - By Material:

• Polymers

• Latex

• Metal

Medical foam made of metallic composites is employed in implantable medical equipment owing to its high features.

Medical Foam Market - By Application:

• Bedding and cushioning

• Medical packaging

• Medical Devices & Components

• Prosthetics & wound care

• Others

The bedding and cushioning segment had a substantial portion of this industry in 2019.

Medical Foam Market - By Region:

• North America Medical Foam Industry includes the U.S. and Canada.

• Europe's Medical Foam Industry includes the UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

• Asia Pacific Medical Foam Industry includes India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

• Latin America Medical Foam Industry includes Brazil, Mexico, Argentina, Chile & Rest of LATAM.

• The Middle East & Africa Medical Foam Industry includes KSA, UAE, Israel, the rest of GCC nations, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA.

Asia-Pacific accounted for the most substantial portion of the global medical foam market in 2019, trailed by the regions of Europe and North America. China is one of the main consumers of medical foam in the Asia-Pacific region. The industry is experiencing expansion here due to demographic changes, rising healthcare spending, industrial development and better economic conditions. The Asia-Pacific region, excluding Japan, is predicted to dominate the worldwide industry for medical foams during the foreseen period. Expansion in the healthcare sector in this region is predicted to boost the industry for medical foams in this area during the foreseen period. Western Europe and North America region are major players in the worldwide medical foam industry and are predicted to achieve positive expansion during the foreseen period. The call-in in this region can be attributed to the high standard of living and consumer awareness of medical foams. In addition, Latin America and Eastern Europe are predicted to experience positive development during the outlook period.

Recent Developments:

Merit Medical launches Torpedo gelatin foam for the embolization of hypervascular tumors. The Torpedo provides clinicians with pre-filled cartridge-filled gelatin foam with an optional blunt style, eliminating the need to manually shape the foam and providing quick and easy attachment to the catheter for delivery.

Medical Foam Market Key Players:

1. The Dow Chemical Company (US)

2. Sekisui Chemical Co., Ltd. (Japan)

3. Huntsman Corporation (US)

4. Trelleborg AB (Sweden)

5. BASF SE (Germany)

6. Recticel NV (Belgium)

7. INOAC Corporation (Japan)

8. UFP Technologies, Inc. (US)

9. FXI Holdings, Inc. (US)

10. Armacell International S.A. (Germany)

11. Rogers Corporation (US),

12. Freudenberg Group (Germany)

13. Molnlycke Health Care (Sweden)